Konto bulbtower4 - Munixo Support Forum

Aktivität von bulbtower4

Dabei seit:	1 Jahr (seit 24, Apr 2025)
Typ:	Konto beantragt
Vollständiger Name:
Ort:
Website:	https://www.selleckchem.com/MEK.html
Beschreibung:	Retraction recognize to "30MO ORIENT-3: Any randomized, open-label, cycle 3 study involving sintilimab compared to docetaxel throughout previously treated advanced/metastatic squamous non-small mobile or portable carcinoma of the lung (sqNSCLC)In .: [Annals of Oncology Volume Thirty-one, Product 6, 12 2020, Web page S1428].